Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Apr 4, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how well patients with stomach cancer respond to surgery before and after the introduction of a special team called the Tumor Board. The Tumor Board is a group of doctors from different areas of medicine who meet weekly to discuss and plan the best treatment for each patient. The main goal of the study is to see if patients have better surgical and cancer outcomes since the Tumor Board started meeting in December 2019, compared to those treated before that time.

To be eligible for this study, participants need to be adults aged 18 and older with a confirmed diagnosis of gastric adenocarcinoma, which is a type of stomach cancer, and they should be candidates for surgery with the goal of curing the cancer. Unfortunately, patients with certain other conditions or types of tumors, as well as those who are pregnant or under 18, cannot participate. If you join the study, you will help researchers understand how a collaborative approach to cancer treatment might improve outcomes for patients like you.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • pathology-confirmed diagnosis of gastric adenocarcinoma
• • age 18 years or older
• • surgical candidates with curative intent
• Exclusion Criteria:
• • Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD)
• • previous EMR or ESD (salvage surgery)
• • histologies other than adenocarcinoma (no squamous cell carcinomas, GISTs, sarcomas, lymphomas, etc)
• • unsufficient staging (unclear clinical stage at diagnosis)
• • emergency presentation (obstrucetd, significantly bleeding, perforated gastric cancer)
• • synchronous tumors affecting survival
• • pregnant patients
• • age \<18years